Giovanni Caforio

Bristol Myers CEO Caforio steps down
Bristol Myers CEO Caforio steps down
Yahoo/Reuters
Bristol Myers Squibb
Pharma CEOs
Giovanni Caforio
Christopher Boerner
Flag link:
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
Flag link:
Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges
Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges
Fierce Pharma
Bristol-Myers Squibb
Giovanni Caforio
Pharma CEOs
executive pay
Flag link:
Bristol Myers to CEO Caforio: Good job on Celgene so far, but you'll have to work for your raise
Bristol Myers to CEO Caforio: Good job on Celgene so far, but you'll have to work for your raise
Fierce Pharma
Bristol-Myers Squibb
Celgene
executive pay
Giovanni Caforio
Flag link:
Bristol Myers CEO Caforio hires a top investment banker from Barclays for his next BD/strategy chief
Bristol Myers CEO Caforio hires a top investment banker from Barclays for his next BD/strategy chief
Endpoints
Bristol-Myers Squibb
M&A
Giovanni Caforio
Flag link:
JPM: Bristol chief says one-third of Celgene cost cuts will hit in 2020
JPM: Bristol chief says one-third of Celgene cost cuts will hit in 2020
Fierce Pharma
M&A
JPMHC 2020
Bristol-Myers Squibb
Celgene
Giovanni Caforio
Flag link:
Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival
Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival
Stat
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
Merck
M&A
Flag link:
Bristol-Myers CEO Giovanni Caforio Named PhRMA Board Chairman
Bristol-Myers CEO Giovanni Caforio Named PhRMA Board Chairman
Xtalks
PhRMA
Giovanni Caforio
Bristol-Myers Squibb
Pharma CEOs
Flag link:
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Fierce Pharma
Bristol-Myers Squibb
Celgene
M&A
drug pricing
Giovanni Caforio
Flag link:
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
CNBC
M&A
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
Flag link:
After winning key support for Celgene buyout, Bristol-Myers CEO Caforio emerges as clear likely winner in looming shareholder vote
After winning key support for Celgene buyout, Bristol-Myers CEO Caforio emerges as clear likely winner in looming shareholder vote
Endpoints
Bristol-Myers Squibb
Celgene
M&A
Starboard
Giovanni Caforio
Flag link:
Bristol-Myers CEO Caforio wants M&A dissidents to know there's been no 'high level' overtures about buying the company since '17
Bristol-Myers CEO Caforio wants M&A dissidents to know there's been no 'high level' overtures about buying the company since '17
Endpoints
Bristol-Myers Squibb
Celgene
Giovanni Caforio
M&A
Flag link:
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
drug pricing
US Congress
Donald Trump
Richard Gonzalez
AbbVie
Ken Frazier
Merck
JNJ
Jennifer Taubert
Olivier Brandicourt
Sanofi
Pascal Soriot
AstraZeneca
Giovanni Caforio
Bristol-Myers Squibb
Albert Bourla
Pfizer
Flag link:
BMS CEO Giovanni Caforio Lays out Reasoning for $74 Billion Acquisition of Celgene
BMS CEO Giovanni Caforio Lays out Reasoning for $74 Billion Acquisition of Celgene
BioSpace
Bristol-Myers Squibb
M&A
Giovanni Caforio
Celgene
Flag link:
Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise
Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise
Fierce Pharma
Bristol-Myers Squibb
Pharma CEOs
Giovanni Caforio
executive pay
Flag link:
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
Fierce Pharma
Bristol-Myers Squibb
Eliquis
Pharma CEOs
Giovanni Caforio
Pfizer
JPMHC 2018
Flag link:
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
Yahoo/CNBC
patients
cancer
Bristol-Myers Squibb
drug pricing
ASCO 2017
Giovanni Caforio
Flag link:
Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit $16.9M
Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit $16.9M
Fierce Pharma
Opdivo
Bristol-Myers Squibb
executive pay
Giovanni Caforio
Flag link:
Bristol-Myers Squibb: A New Chapter, and the Beginning of Sustained Growth
Bristol-Myers Squibb: A New Chapter, and the Beginning of Sustained Growth
Motley Fool
Bristol-Myers Squibb
Giovanni Caforio
Flag link:
New CEO takes over evolving drugmaker Bristol-Myers Squibb
New CEO takes over evolving drugmaker Bristol-Myers Squibb
Yahoo/AP
Pharma CEOs
Bristol-Myers Squibb
Giovanni Caforio
Flag link:

Pages